Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Versartis (VSAR) Announces $75M Common Offering
-
Versartis Announces Proposed Offering of Common Stock
-
Canaccord Genuity Upgrades Gran Tierra Energy (GTE) to Buy
-
Canaccord Genuity Downgrades Precision Castparts (PCP) to Hold
-
Canaccord Genuity Downgrades American Eagle Energy (AMZG) to Hold
-
Canaccord Genuity Downgrades Abraxas Petroleum (AXAS) to Hold
-
QAD, Inc. (QADA) Prices 3M Common Offering at $20/Share
-
Paycom Software (PAYC) Prices 5.585M Share Offering at $22.50/Share
-
Canaccord Genuity Upgrades Magna Int'l (MGA) to Buy
-
Canaccord Genuity Starts Crane (CR) at Hold
-
Canaccord Genuity Downgrades Datawatch Corp (DWCH) to Hold
-
Apple (AAPL) iPhone 6/6+ U.S. Demand Strong into January; Canaccord Boosts Q115 Shipment Outlook
-
Yamana Gold (AUY) Announces C$260M Bought Deal Financing Arrangement
-
Canaccord Genuity Downgrades NPS Pharmaceuticals Inc. (NPSP) to Hold
-
Notable Analyst Rating Changes 1/9: (WYNN) (BAH) (EXC) Upgraded; (NUAN) (ABBV) (NBR) Downgraded
-
Pre-Open Stock Movers 01/09: (AGEN) (SD) (YELP) Higher; (WTSL) (CNAT) (ARGS) Lower (more...)
-
UPDATE: Canaccord Genuity Starts Vanda Pharmaceuticals (VNDA) at Buy
-
Cara Therapeutics (CARA) May Have 'Holy Grail' Alt. to Opiods; Canaccord Starts at Buy
-
Box, Inc. (BOX) Sees IPO Price of $11 - $13/Share
-
Notable Analyst Rating Changes 1/8: (MGM) (WEN) (TSCO) Upgraded; (AIG) (ADM) (DKS) Downgraded
-
Canaccord Genuity Starts Sarepta Therapeutic (SRPT) at Hold
-
Canaccord Genuity Starts Ultragenyx Pharma (RARE) at Buy
-
Canaccord Genuity Starts Synageva BioPharma (GEVA) at Buy
-
Canaccord Genuity Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
-
Canaccord Genuity Starts Alnylam Pharmaceuticals (ALNY) at Buy
-
PlacementTracker Publishes 2014 PIPE Market League Tables
-
Notable Analyst Rating Changes 1/7: (JNS) (AXP) (NLST) Upgraded; (FOSL) (PRGN) (INFA) Downgraded
-
Radius Health (RDUS) PT Raised 75% at Canaccord Genuity
-
Amazon.com (AMZN) PT Cut to $300 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Downgrades Baltic Trading Limited (BALT), Paragon Shipping (PRGN) to Hold
-
Canaccord Genuity Downgrades Paragon Shipping Inc. (PRGN) to Hold
-
Notable Analyst Rating Changes 1/6: (ORCL) (FDX) (LOCO) Upgraded; (INFN) (GE) (KORS) Downgraded
-
Kite Pharma (KITE) PT Raised to $90 at Canaccord Genuity
-
Canaccord Genuity Starts Ambarella (AMBA) at Buy
-
Canaccord Genuity Starts Histogenics Corp. (HSGX) at Buy
-
Notable Analyst Rating Changes 1/2: (LH) (BBBY) (FNF) Upgraded; (FTI) (SWIR) (XRAY) Downgraded
-
Canaccord Genuity Upgrades Bed Bath & Beyond (BBBY) to Buy
-
Avinger (AVGR) Files $69M IPO
-
HTG Molecular Diagnostics (HTGM) Files $60M IPO
-
CalAmp (CAMP) PT Lowered at Canaccord Genuity Post Q3; 'Buy' Maintianed
-
Entellus Medical (ENTL) Files $69M IPO
-
Canaccord Genuity Comments on Renewed T-Mobile US (TMUS) Takeover Rumors
-
OraSure Technologies (OSUR) PT Raised to $14 at Canaccord Genuity; Called Top Pick
-
Jamba (JMBA) PT Lifted to $16 at Canaccord Genuity
-
EQT Corp. (EQT) PT Raised to $104 at Canaccord Genuity
-
Sierra Wireless (SWIR) PT Raised to $53 at Canaccord Genuity
-
Canaccord Genuity Downgrades Finish Line (FINL) to Hold
-
Canaccord Genuity Downgrades Barrick Gold (ABX) to Sell
-
Canaccord Genuity Upgrades Dakota Plains Holdings (DAKP) to Buy
-
Canaccord Genuity Notes Signs of Stability at Nu Skin (NUS)

